A philosophical perspective on pulmonary hypertension : what is 'rare'?
dc.contributor.author | Maarman, Gerald J. | en_ZA |
dc.date.accessioned | 2021-07-21T12:28:20Z | |
dc.date.available | 2021-07-21T12:28:20Z | |
dc.date.issued | 2020-05-27 | |
dc.description | CITATION: Maarman, G. J. 2020. A philosophical perspective on pulmonary hypertension : what is 'rare'? South African Journal of Science, 116(5/6):#7939, doi:10.17159/sajs.2020/7939. | |
dc.description | The original publication is available at https://www.sajs.co.za | |
dc.description.abstract | ENGLISH ABSTRACT: Pulmonary hypertension (PH) is a fatal disease and public health concern.1 The global prevalence of PH is not known1 and a major focus is to establish registries in order to determine the actual prevalence of PH per country2. PH prevalence is largely subject to aetiology, geographical region and the tools used to make a diagnosis (e.g. echocardiography or right heart catheterisation).1 In Africa, the prevalence of PH that is secondary to HIV differs from its prevalence that is secondary to rheumatic heart disease or schistosomiasis. For example, PH prevalence in HIV is approximately 14%3, while the prevalence can be 1% or 10% in schistosomiasis4. In comparison with a world population of some eight billion people, the relatively ‘low’ number of people who have been diagnosed with or who have succumbed to PH has triggered the assumption that it is a rare disease, which is how it is also reported throughout the literature. | en_ZA |
dc.description.version | Publisher's version | |
dc.format.extent | 1 page | en_ZA |
dc.identifier.citation | Maarman, G. J. 2020. A philosophical perspective on pulmonary hypertension : what is 'rare'? South African Journal of Science, 116(5/6):#7939, doi:10.17159/sajs.2020/7939. | |
dc.identifier.issn | 1996-7489 (online) | |
dc.identifier.orcid | https://orcid.org/0000-0003-3336-5594 | |
dc.identifier.other | doi:10.17159/sajs.2020/7939 | |
dc.identifier.uri | http://hdl.handle.net/10019.1/110767 | |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | ASSAf | en_ZA |
dc.rights.holder | Author retains copyright | en_ZA |
dc.subject | Pulmonary hypertension | en_ZA |
dc.subject | HIV-infected persons | en_ZA |
dc.subject | Diseases -- Mortality | en_ZA |
dc.subject | Comorbidity | en_ZA |
dc.title | A philosophical perspective on pulmonary hypertension : what is 'rare'? | en_ZA |
dc.type | Article | en_ZA |